Shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.90 and traded as low as $0.89. Oxbridge Re shares last traded at $0.9199, with a volume of 6,125 shares traded.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings downgraded shares of Oxbridge Re from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.
Read Our Latest Research Report on OXBR
Oxbridge Re Price Performance
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last released its earnings results on Saturday, February 14th. The insurance provider reported $0.02 EPS for the quarter. The business had revenue of $0.58 million for the quarter. Oxbridge Re had a negative net margin of 76.47% and a negative return on equity of 33.33%.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in OXBR. Virtu Financial LLC purchased a new position in Oxbridge Re during the third quarter valued at approximately $32,000. International Assets Investment Management LLC purchased a new position in Oxbridge Re during the fourth quarter valued at approximately $39,000. J.W. Cole Advisors Inc. purchased a new position in Oxbridge Re during the third quarter valued at approximately $59,000. Finally, Henrickson Nauta Wealth Advisors Inc. grew its position in Oxbridge Re by 100.0% during the fourth quarter. Henrickson Nauta Wealth Advisors Inc. now owns 137,400 shares of the insurance provider’s stock valued at $185,000 after purchasing an additional 68,700 shares in the last quarter. 5.64% of the stock is owned by hedge funds and other institutional investors.
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Read More
- Five stocks we like better than Oxbridge Re
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
